Consulting on drug metabolism and pharmacokinetics for pain management
Official title: SUBJECT MATTER EXPERT CONSULTANT FOR DRUG METABOLISM PHARMACOKINETICS [DMPK]
Funded at Allucent Government Services (Us) LLC · NIH-11041950 · Data updated 2026-11-12
This study is all about finding better ways to manage pain by looking at how medications work in the body, and it aims to help patients by improving new pain treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Allucent Government Services (Us) LLC NIH-funded |
| Lab location | 1 site (Cary, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $134,440 |
| NIH project number | 75N95022P00352-P00006-0-1 |
| Project ID | NIH-11041950 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing chronic pain who may benefit from new pain management therapies.
✕Less likely to help
Patients who do not experience chronic pain or are not seeking new pain management options may not benefit from this research.
What this research studies
This research focuses on improving pain management by evaluating and optimizing drug metabolism and pharmacokinetics. The project involves consulting services to assess study protocols and data, identifying challenges in drug discovery and development, and recommending strategies to overcome these obstacles. Additionally, it includes designing pharmacokinetics studies and facilitating discussions among development teams to enhance the effectiveness of investigational drugs. Patients may benefit from advancements in pain therapies resulting from this work.
Why it matters
Potential benefit: If successful, this research could lead to more effective pain management therapies for patients suffering from chronic pain.
How similar studies have gone: Previous research in pharmacokinetics and drug development has shown promise in improving pain management strategies, indicating that this approach is built on established methodologies.
Where this research is happening
-
Allucent Government Services (Us) LLC
Cary, United States Active
Researchers
- Principal investigator: Martin, William — Allucent Government Services (Us) LLC
- Study coordinator: Martin, William
Related research
Other NIH-funded projects on the same topics.
-
Sub-second acetylcholine release in the brain for Alzheimer’s dementia
A small, quick stimulations-based study aims to boost a brain chemical called acetylcholine to help people with Alzheimer’s disease by using a targeted brain stimulation approach.
-
Understanding how broadly neutralizing antibodies may help HIV cure trials
A study at UC San Francisco looks at how antibody medicines behave in people on and off HIV therapy to help design better cure strategies.
-
Improving HIV-related brain infections by studying how drugs reach the brain
This grant looks at how well drugs reach the brain and spine to treat HIV-related infections like cryptococcal meningitis and TB meningitis in people with AIDS.
-
Transdermal delivery patch for zanamivir to treat influenza in patients
A new skin patch delivers zanamivir to people with flu or at risk of flu, aiming for easier, safer treatment than pills.
-
Chesapeake-Ohio Pharmacokinetics Core supports cancer drug testing
A collaborative core lab helps researchers study how cancer drugs behave in the body to improve clinical trials and patient care.
-
Urine color test to check tuberculosis drug levels in children and adults
This project uses a simple urine color test to see whether children and adults with TB are getting enough of key TB medicines like rifampin.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.